Inhibition of 3,4-methylenedioxymethamphetamine (MDMA) metabolism leads to marked decrease in 3,4-dihydroxymethamphetamine (HHMA) formation but no change in serotonin neurotoxicity: Implications for mechanisms of neurotoxicity

Samankaltaisia teoksia

• Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
  Tekijä: McCann, Una D., et al.
  Julkaistu: (2007)
• Studies of (±)-3,4-Methylenedioxymethamphetamine (MDMA) Metabolism and Disposition in Rats and Mice: Relationship to Neuroprotection and Neurotoxicity Profile
  Tekijä: Mueller, Melanie, et al.
  Julkaistu: (2013)
• Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity
  Tekijä: Mueller, Melanie, et al.
  Julkaistu: (2009)
• Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery
  Tekijä: Hatzidimitriou, George, et al.
  Julkaistu: (1999)
• Metabolism and Disposition of 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Baboons after Oral Administration: Comparison with Humans Reveals Marked Differences
  Tekijä: Mueller, Melanie, et al.
  Julkaistu: (2011)